A Lancet Oncology commission report presented at the American Society of Clinical Oncology’s annual meeting warns that by 2050 the global cancer workforce could shrink by 100 million, driven by oncologist burnout, rising cancer cases and an ageing population. Nearly half of oncologists are considering quitting, and a quarter regret their career choice, the report says,while cancer diagnoses are projected to reach 35.3 million per year.

Projected 35.3 Million New Cancer Cases by 2050

The commission’s figures show a 21 % rise in new cancer diagnoses by 2050, equating to roughly 100,000 new cases each day.. This surge, coupled with an ageing global population, creates a “perfect storm” that could overwhelm existing health systems, according to the report.

100 Million‑Worker Shortfall: Nursing and Diagnostics Hit Hardest

According to the study, the most acute deficits will be in nursing and diagnostic roles, with a potential loss of up to 100 million cancer‑care workers worldwide. The shortage would force patients into emergency department corridors and leave terminally ill individuals parked outside nursing stations, the report notes.

One‑Third of Patients Remain Undiagnosed Today

The commission highlights that about 33 % of cancer patients worldwide remain undiagnosed, underscoring the fragility of current diagnostic frameworks. This gap is expected to widen if workforce shortages continue, the report warns.

Urgent Calls for National Cancer Plans and Funding

In response, the report urges governments to implement comprehensive national cancer plans, invest in technology and education, and provide sustained funding to expand the workforce. It stresses that “proojections cannot be waited for; immediate action is required to avert a global health catastrophe.”

UK Services Already Struggling: A Case Study

Experts in the UK point to patients being treated in emergency department corridors and the risk of missed diagnoses if proposed cuts to unnecessary appointments are enacted. the report stresses that specialist training and retention must be prioritised to avoid continued failure for cancer patients.

Who Will Fill the Gap? The Unnamed Buyers of Training?

While the commission calls for coordinated international efforts,it does not specify which countries or institutions will lead the training surge.. the question remains: who will invest the billions needed to train the next generation of oncologists, nurses and diagnosticians?